Tradestie Institutional Equity Comparison Engine

BLLN vs SHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SHC Overall Edge

SHC Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sotera Health Company Common Stock (SHC) driven by superior Valuation, Growth & Margin, Options & Structure while BLLN counters with relative strength in Momentum & Technical. Fundamentally, BLLN trades at 61.3x Forward P/E with 10.2% operating margin (+47.2% YoY revenue) versus SHC at 15.3x Forward P/E and 36.8% operating margin (+4.4% YoY). In options structure, BLLN sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against SHC sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SHC
BLLN 61.3x vs SHC 15.3x Fwd P/E
Growth & Margin Winner SHC
Op Margin 10.2% vs 36.8% ยท YoY +47.2% vs +4.4%
Momentum & Technical Winner BLLN
1Y +7.5% vs +1.5% ยท 52W Pos 39% vs 47%
Options & Structure Winner SHC
BREAKDOWN (26th %ile IV) vs UNCLASSIFIED (6th %ile IV)
BLLN US Equity
BillionToOne, Inc.
Services-Medical Laboratories
$96.31
-8.41% 1D
Market Cap $5.0B
1M Return -1.84%
1Y Return +7.55%
Forward P/E 61.3x
Unified AI Score
45.8 / 100 HOLD
Tech 27.0 Fund 53.0 Flow 71.0 Mom 70.0
SHC NASDAQ
Sotera Health Company Common Stock
Services-Misc Health & Allied Services, Nec
$16.25
-2.17% 1D
Market Cap $4.7B
1M Return -9.17%
1Y Return +1.5%
Forward P/E 15.3x
Unified AI Score
63.1 / 100 BUY
Tech 60.0 Fund 56.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BLLN +7.55% SHC +1.5% Spread: +6.05 pp (BLLN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BLLN TTM Op. Margin: 10.2% SHC TTM Op. Margin: 36.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BLLN vs SHC. Trailing 12-month operating profitability (BLLN 10.2% vs SHC 36.8%) and valuation multiples (BLLN 61.3x vs SHC 15.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BLLN (3) vs SHC (7)
Institutional Metric BLLN SHC Criterion Row Winner
Market Capitalization Scale $5.0B $4.7B Larger Scale BLLN
Trailing P/E Ratio Valuation 114.3x 27.7x Lower Multiple SHC
Forward P/E Ratio Valuation 61.3x 15.3x Lower Multiple SHC
Revenue Growth (YoY) Growth +47.2% +4.4% Higher Growth BLLN
Operating Margin (TTM) Profitability 10.2% 36.8% Higher Margin SHC
Net Profit Margin Profitability 10.5% 14.1% Higher Margin SHC
Return on Equity (ROE) Capital Efficiency 13.2% 27.0% Higher ROE SHC
52-Week Range Position Momentum 39% ($62โ€“$150) 47% ($13โ€“$20) Stronger Trend SHC
Beta / 30D Volatility Risk Regime 1.44ฮฒ ยท 42% Vol 0.95ฮฒ ยท 44% Vol Lower Realized Risk BLLN
Unified Institutional Score Composite Signal 45.8 / 100 (HOLD) 63.1 / 100 (BUY) Higher Composite SHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BLLN vs SHC Buy Guide
BLLN BREAKDOWN
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BLLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SHC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live SHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BLLN nor SHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.